The fight over copycat weight-loss drugs escalates
An intensifying showdown over copycat GLP-1 weight-loss drugs is pitting the Trump administration and drug companies against compounding pharmacies and some telehealth companies. AXIOS
An intensifying showdown over copycat GLP-1 weight-loss drugs is pitting the Trump administration and drug companies against compounding pharmacies and some telehealth companies. AXIOS